AGP Picks
View all

The latest news from Massachusetts

Provided by AGP

Bay State Times
Got News to Share?
Got News to Share? globe Explore more publications!

Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 1, 2026

Wayside Youth & Family Support Network Earns Prestigious 2026 USA TODAY Top Workplaces Award for Fourth Consecutive Year
May 1, 2026

Wayside Youth & Family Support Network Earns Prestigious 2026 USA TODAY Top Workplaces Award for Fourth Consecutive Year

Indeterminate EIN Presswire
RealCISO Launches 2.0, Rebuilding Compliance Platform Around Program Maturity Instead of Checklists
May 1, 2026

RealCISO Launches 2.0, Rebuilding Compliance Platform Around Program Maturity Instead of Checklists

Indeterminate EIN Presswire
Spyre Therapeutics Announces Grants of Inducement Awards
May 1, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call
May 1, 2026

Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire
Roblox Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm to Recover Losses
May 1, 2026

Roblox Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm to Recover Losses

Indeterminate GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 1, 2026

Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
General Catalyst Global Resilience Merger Corp. Announces Closing of $402.5 Million Initial Public Offering
May 1, 2026

General Catalyst Global Resilience Merger Corp. Announces Closing of $402.5 Million Initial Public Offering

Indeterminate GlobeNewswire
Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments
May 1, 2026

Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments

Indeterminate GlobeNewswire
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
May 1, 2026

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
May 1, 2026

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Bay State Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.